Christopher Hogbin
Known title: Global Head of InvestmentsCIK: 0002006999
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
AllianceBernstein Faces Lower Price Targets Amid Wildfire Risk Concerns. Three major firms recently lowered their price targets for AllianceBernstein, citing increased wildfire risk as a potential threat to investment returns. This news coincides with the stock trading near its established support level, reflecting cautious sentiment. Despite the reduced targets, the company continues to offer a high dividend yield, which remains a key feature for income-focused observers.
Transaction History
| LAZ | ▼ Sell | Open Market | 3,944 | $155K | 3/19/2026 | View on chart |
| LAZ | ▼ Sell | Open Market | 7,885 | $318K | 3/18/2026 | View on chart |
| LAZ | ▲ Buy | Option Exercise | 48,332 | — | 3/17/2026 | View on chart |
| LAZ | ▼ Sell | Tax Withholding | 24,674 | $988K | 3/17/2026 | View on chart |
| AB | ▼ Sell | Gift | 10,000 | $402K | 5/6/2025 | View on chart |
| AB | ▼ Sell | Open Market | 6,026 | $246K | 5/5/2025 | View on chart |
| AB | ▲ Buy | Grant | 71,153 | $2.6M | 12/11/2024 | View on chart |
| AB | ▼ Sell | Tax Withholding | 9,424 | $342K | 12/2/2024 | View on chart |
| AB | ▼ Sell | Tax Withholding | 6,026 | $219K | 12/2/2024 | View on chart |
| AB | ▼ Sell | Open Market | 12,781 | $446K | 7/29/2024 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Lazard faces lowered price targets from Morgan Stanley and UBS
Morgan Stanley and UBS recently cut their price targets for Lazard to $41 and $40, respectively, while maintaining Underweight and Neutral ratings. This move aligns with broader market concerns about rising bond yields and the firm's high 7.25% dividend yield, which some analysts view as stretched. The stock is currently trading near its support level, reflecting the cautious sentiment from these recent analyst actions.
Lazard faces lowered price targets from Morgan Stanley and UBS. Morgan Stanley and UBS recently cut their price targets for Lazard to $41 and $40, respectively, while maintaining Underweight and Neutral ratings. This move aligns with broader market concerns about rising bond yields and the firm's high 7.25% dividend yield, which some analysts view as stretched. The stock is currently trading near its support level, reflecting the cautious sentiment from these recent analyst actions.